Stroke Trial, Recruiting NCT06691230 Sponsor: Insel Gruppe AG, University Hospital Bern Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06691230
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be willing to participate and have signed a consent form agreeing to take part
  • You must have undergone a procedure to remove a blood clot from a blood vessel in the brain, or a procedure was planned but only a diagnostic scan (to look at the blood vessels) was carried out instead
  • You must have received a specific type of brain scan called FDCTP (a CT imaging scan), as recommended by your doctor

Who may not be able to join:

  • You may not be able to join if you are not able to give consent because you do not speak or understand the language used in this study well enough
  • You may not be able to join if you are unable to attend a follow-up appointment 90 days after your stroke, for example if you live in another country

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Johannes Kaesmacher, Prof., University of Bern

Phone: +41 31 66 4 05 38

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Insel Gruppe AG, University Hospital Bern
Registry
ClinicalTrials.gov
Start date
1 November 2024
Est. completion
30 November 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Detection of New Potentially Clinically Relevant Findings on FDCTP

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov